WCN25-1028 SODIUM GLUCOSE COTRANSPORTER TYPE 2 INHIBITORS IN THE CONTROL OF ALBUMINURIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE, STUDY IN A MEXICAN CENTER

WCN25-1028 SODIUM GLUCOSE COTRANSPORTER TYPE 2 INHIBITORS IN THE CONTROL OF ALBUMINURIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE, STUDY IN A MEXICAN CENTER

Saved in:

Bibliographic Details
Main Authors:	Alan Arzeta Popoca, Gabriela Salas Pérez, María Sofia Hernández de la Cruz, José Luis Gálvez Romero, Óscar Palmeros Rojas, Kriscia Mariela Hernández Arteaga, Sarah Emperatriz Santana Marban
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S246802492402312X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sodium Chloride Cotransporter in Hypertension
by: Annalisa Castagna, et al.
Published: (2024-11-01)

WCN24-1028 IMPACT OF HEMODIALYSIS ACCESS ON EARLY POST-TRANSPLANT OUTCOMES AMONG LIVE-RELATED RENAL ALLOGRAFT RECIPIENTS
by: D.H.A.R.S.H.A.N. RANGASWAMY, et al.
Published: (2024-04-01)

WCN25-3716 PREVALENCE OF HYPOTHYROIDISM IN HEMODIALYSIS AND A SPECIFIC CUT-OFF POINT FOR ITS DIAGNOSIS
by: Raquel Rosas Tototzintle, et al.
Published: (2025-02-01)

Cardioprotective mechanisms of sodium-glucose cotransporter 2 inhibitors
by: A. M. Mkrtumyan, et al.
Published: (2021-09-01)

SODIUM-POTASSIUM-CHLORIDE COTRANSPORT IN THE REGULATION OF VASCULAR MYOGENIC TONE
by: S. N. Orlov, et al.
Published: (2014-12-01)

Sodium-glucose cotransporter 2 inhibitors as potential anticancer agents
by: E. R. Radkevich, et al.
Published: (2025-05-01)

Sodium-glucose cotransporter 2 inhibitor for the treatment of diabetic nephropathy
by: Kong Ling-li, et al.
Published: (2021-01-01)

WCN24-927 SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR FOR PREVENTION OF CONTRAST-INDUCED NEPHROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: Jayson Villavicencio, et al.
Published: (2024-04-01)

WCN25-2284 GENOTYPE-DEPENDENT ALBUMINURIA IN ADULT SICKLE CELL DISEASE IN KINSHASA
by: Yannick Engole, et al.
Published: (2025-02-01)

Sodium–Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction
by: Nicia I. Profili, et al.
Published: (2025-03-01)

Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Kidney Disease and beyond
by: Zein Alabdin Hannouneh, et al.
Published: (2025-01-01)

Sodium Glucose Cotransporter Inhibition in Acute Heart Failure: An In-Depth Review
by: Joey A. Mercier, MD, FRCPC, et al.
Published: (2025-04-01)

Treatment of Heart Failure with Sodium-glucose Cotransporter Type 2 Inhibitors
by: Riber Fabián Donoso Noroña, et al.
Published: (2024-09-01)

Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
by: Yoko Takatsuna, et al.
Published: (2020-01-01)

Antifibrotic effects of sodium-glucose cotransporter 2 inhibitors in patients with heart failure
by: Yu. S. Ignatova, et al.
Published: (2024-02-01)

Perioperative euglycemic DKA: The YIN and YANG of sodium-glucose cotransporter 2 inhibitors
by: Shilpushp Bhosale, et al.
Published: (2025-01-01)

Timing and Adherence Matter for Sodium–Glucose Cotransporter‐2 Inhibitors in Heart Failure
by: Mehmet Birhan Yilmaz, et al.
Published: (2025-04-01)

Sodium-glucose cotransporter-1 inhibition and depression: A Mendelian randomization study
by: Gang Fan, et al.
Published: (2025-07-01)

The roles of sodium-potassium-chloride cotransporter isoform-1 in acute lung injury
by: Po-Chun Hsieh, et al.
Published: (2022-01-01)

Transporting Sodium-Glucose Cotransporter-2 Inhibitors to the African Continent: Challenges and Solutions
by: Valerie A. Luyckx, et al.
Published: (2024-03-01)

Effects of sodium-glucose cotransport-2 inhibitors treatment in patients with pulmonary hypertension
by: Mohammed Obeidat, et al.
Published: (2025-06-01)

Sodium-Glucose Cotransporter-2 Inhibitor in Diabetic and Nondiabetic Renal Transplant Recipients
by: Lucie Maigret, et al.
Published: (2025-03-01)

Sodium glucose cotransporter 2 inhibitors are associated with renal stabilization in heart transplantation
by: Lisa M. Raven, MBBS, FRACP, et al.
Published: (2025-05-01)

Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An Update
by: Nicia I. Profili, et al.
Published: (2024-10-01)

WCN24-1550 ALDOSTERONE SYNTHASE INHIBITION WITH OR WITHOUT BACKGROUND SODIUM GLUCOSE COTRANSPORTER 2 INHIBITION IN CKD: A PHASE II CLINICAL TRIAL
by: Katherine Tuttle, et al.
Published: (2024-04-01)

Sodium-glucose cotransporter type 2 inhibitors: successful running after two hares
by: N. B. Perepech, et al.
Published: (2021-07-01)

Ocular outcomes of the sodium-glucose cotransport inhibitors: A systematic review of cohort studies
by: Nathaniel Eraikhuemen, et al.
Published: (2025-04-01)

Effect of Sodium-Glucose Cotransporter Type 2 Inhibitors on The Development and Course of Atrial Fibrillation
by: D. A. Ishmaev, et al.
Published: (2025-01-01)

Evaluation of factors influencing adherence to treatment with sodium-glucose cotransporter type 2 inhibitor
by: D. A. Lebedev, et al.
Published: (2020-10-01)

Role of sodium-glucose cotransporter 2 inhibitors in cardiovascular events in patients with heart failure
by: Eva Muja, et al.
Published: (2025-07-01)

The effect of sodium-glucose cotransporter 2 inhibition mediated by blood metabolites in lymphocytic leukemia
by: Diguang Wen, et al.
Published: (2025-11-01)

Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)
by: Ashot A. Avagimyan, et al.
Published: (2025-02-01)

Unmasking of normocalcemic primary hyperparathyroidism after sodium-glucose cotransporter-2 inhibitor initiation
by: Christodoulos Dolapsakis, et al.
Published: (2025-01-01)

Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
by: Muhammad Shahzeb Khan, et al.
Published: (2019-11-01)

Diabetic Ketoacidosis as an Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Real World Insights
by: Han-Sang Baek, et al.
Published: (2024-11-01)

WCN24-1347 CLINICAL PRESENTATION AT THE TIME OF DIAGNOSIS IN A COHORT OF MEXICAN PATIENTS WITH IGA NEPHROPATHY
by: Estefania Garduño Hernandez, et al.
Published: (2024-04-01)

WCN25-2945 ADHERENCE TO ANTIHYPERTENSIVE TREATMENT IN PATIENTS UNDERGOING HEMODIALYSIS : SINGLE CENTER STUDY IN PUEBLA, MEXICO
by: Sergio Victor Pérez Reyes, et al.
Published: (2025-02-01)

WCN25-2620 CUMULATIVE EFFECTS OF THE ALDOSTERONE SYNTHASE INHIBITOR VICADROSTAT COMBINED WITH EMPAGLIFLOZIN ON ALBUMINURIA IN PEOPLE WITH CKD
by: Peter Rossing, et al.
Published: (2025-02-01)

Sodium–Glucose Cotransporter 2 Inhibitors as Potential Antioxidant Therapeutic Agents in Cardiovascular and Renal Diseases
by: Tapan A. Patel, et al.
Published: (2025-03-01)

Genomic insights about the effect of sodium-glucose cotransporter 2 inhibitors: a systematic review
by: Pavitraa Saravana Kumar, et al.
Published: (2025-05-01)